A supplement is a product sold to add a nutrient, herb, amino acid, enzyme, or other bioactive to the diet without meeting the regulatory bar of a drug. In the United States the FDA regulates these under the Dietary Supplement Health and Education Act of 1994 and the Federal Food, Drug, and Cosmetic Act. Firms are responsible for lawful and safe products before marketing, including compliant labeling, substantiated and truthful claims, current good manufacturing practice, and new dietary ingredient notifications where applicable; FDA can act against adulterated or misbranded products after they reach market. That framework shapes almost every downstream decision a user makes about dose, brand, and trust.
The regulatory gap in plain terms
Drugs must prove efficacy and safety before sale. Supplements generally do not need FDA pre-approval, but firms must ensure the product is not adulterated or misbranded, follow supplement cGMP, use required labeling, substantiate claims, avoid disease-treatment claims, and submit required notifications for certain structure-function claims and new dietary ingredients. The FDA acts mostly post-market, meaning contaminated, mislabeled, or under-dosed products are typically caught after consumer reports, inspections, or testing rather than before shelf placement. ConsumerLab, Labdoor, and USP have repeatedly found 10–40% of products in various categories failing label claims by more than 10%. A user cannot rely on the label alone, which is why regulatory categories and third-party testing matter more here than in any drug aisle.
How supplements differ from adjacent categories
| Category | Oversight | Proof required before sale | Example |
|---|---|---|---|
| Prescription drug | FDA NDA approval | Efficacy, safety, GMP | Levothyroxine 50 mcg |
| OTC drug | FDA monograph | Efficacy for claimed use | Ibuprofen 200 mg |
| Dietary supplement | FDA framework under DSHEA and FD&C Act | Manufacturer responsibility; no FDA premarket proof, except NDI notification where applicable | Vitamin D3 2,000 IU |
| Medical food | FDA medical food rules, clinician-directed | Specific nutritional need | Medical-food amino acid formula |
| Functional food | Standard food rules | Food-safety compliance | Fortified cereal, electrolyte mix |
A product can shift categories depending on the claim. "Supports healthy sleep" is a permissible structure-function claim for a supplement. "Treats insomnia" is a drug claim and is not legally available on a supplement label.
What to verify before trusting a product
Before a product enters a stack, four checks do most of the work:
- An independent test certificate from USP, NSF, Informed Sport, or ConsumerLab that matches the current lot.
- Clear active-compound amounts, not proprietary-mixture totals. A 500 mg proprietary mixture of six herbs tells a user nothing about any single ingredient.
- A Certificate of Analysis for heavy-metal and microbial contamination, especially for botanicals, green powders, and imported herbals.
- A current interaction check against prescription medications, since St John's wort, high-dose niacin, and vitamin K2 alone cause hundreds of documented drug interactions.
The trust stack in one example
A 1,000 mg fish-oil softgel can contain anywhere from 300 mg to 850 mg of combined EPA and DHA depending on concentration, and oxidation levels vary widely across brands. Two products at the same shelf price can deliver a 2x difference in active omega-3 per dollar and a 3x difference in peroxide value. The ingredient form field and third-party oxidation testing are what separate the two, not the front label.
Uncertainty users should hold
- Evidence strength varies by ingredient and by outcome. Creatine for strength has hundreds of trials. Many herbals have fewer than five controlled trials at any dose.
- Label claims about "clinically studied" often cite a study on a different dose, form, or population than the one on the shelf.
- Response varies meaningfully by genotype, baseline nutritional status, medication overlap, and age. A dose that helps one user may do nothing in another.
For the pathway from a single supplement to a safe, sequenced stack, see foundation supplement and the minimum viable stack entry.
How this appears in Unfair
Unfair treats every library entry as a supplement unless pharmaceutical-grade controls are documented, and it attaches a trust profile to each entry covering regulatory status, testing certificates where known, and interaction flags. The stack builder filters out claims the product cannot legally carry, keeps proprietary-mixture entries labeled as unknown-dose, and surfaces third-party testing status on the detail view before the user commits.
Clinical safety note
If a supplement is followed by chest pain, fainting, jaundice, unusual bleeding, rash, swelling, persistent GI pain, or any change in mental status, stop it, save the bottle and lot number, and contact a clinician or poison control. Report adverse events through the FDA MedWatch program so patterns become visible to others.